Showing Form 4 filings for PHIO
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Phio Pharmaceuticals Corp.
Price
$1.04
Shares
10,000
Ownership
42,000
Value/Share
$1.03
Plott Ronald Todd
Dir
Industry
$1.01
6,500
64,151
Bradford Patricia A